The Cardiopulmonary Effects of the Calcitonin Gene-related Peptide Family

Abstract

Cardiopulmonary diseases are very common among the population. They are high -cost diseases and there are still no definitive treatments. The roles of members of the calcitonin-gene related -peptide (CGRP) family in treating cardiopulmonary diseases have been studied for many years and promising results obtained. Especially in recent years, two important members of the family, adrenomedullin and adrenomedullin2/intermedin, have been considered new treatment targets in cardiopulmonary diseases. In this review, the roles of CGRP family members in cardiopulmonary diseases are investigated based on the studies performed to date.